Marino Michael F III
SEC insider (Form 3/4/5 filer). CIK 0001502700. Officer at NewAmsterdam Pharma Co N.V. (NAMS) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 1, 2025. Located in YARDLEY, PA.
Companies Marino Michael F III has filed insider reports for
- NewAmsterdam Pharma Co N.V. (NAMS): Officer, See Remarks
- OptiNose, Inc. (OPTN): Officer, Chief Legal Officer & Corp Sec
Marino Michael F III
CIK: 0001502700
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)4 (57.1%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (28.6%)
Compensation grants
Other (G, F, J, C, D, …)1 (14.3%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 1, 2025NAMS
NewAmsterdam Pharma Co N.V.
AwardDirect55K shares- - May 21, 2025OPTN
OptiNose, Inc.
DispositionDirect125.2K shares- - Mar 18, 2025OPTN
OptiNose, Inc.
SaleDirect246 shares at avg. $5.61$1K - Mar 4, 2025OPTN
OptiNose, Inc.
SaleDirect2.1K shares at avg. $5.29$11K - Feb 21, 2025OPTN
OptiNose, Inc.
AwardDirect21.2K shares- - Dec 17, 2024OPTN
OptiNose, Inc.
SaleDirect3.1K shares at avg. $0.44$1K - Sep 17, 2024OPTN
OptiNose, Inc.
SaleDirect3.2K shares at avg. $0.87$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 1, 2025 |  NAMS NewAmsterdam Pharma Co N.V. | Award | 55,000 | - | - | Direct |
| May 21, 2025 |  OPTN OptiNose, Inc. | Disposition | 125,204 | - | - | Direct |
| Mar 18, 2025 | OPTN OptiNose, Inc. | Sale | 246 | $5.61 | $1,380 | Direct |
| Mar 4, 2025 | OPTN OptiNose, Inc. | Sale | 2,145 | $5.29 | $11,347 | Direct |
| Feb 21, 2025 | OPTN OptiNose, Inc. | Award | 21,150 | - | - | Direct |
| Dec 17, 2024 | OPTN OptiNose, Inc. | Sale | 3,050 | $0.44 | $1,342 | Direct |
| Sep 17, 2024 | OPTN OptiNose, Inc. | Sale | 3,226 | $0.87 | $2,807 | Direct |
1-7 of 7 transactions